Search - tctmd.com

Displaying 361 - 380 of 1823

Sort: Relevancy | Date

News Conference News ACC 2020

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Michael O'Riordan

March 30, 2020

Presentation ACC 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presenter: Yangsoo Jang

March 30, 2020

News Conference News ACC 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

L.A. McKeown

March 28, 2020

News Conference News ACC 2020

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

Michael O'Riordan

March 28, 2020

News Opinion Conversations in Cardiology

Conversations in Cardiology: Uncovered Struts on OCT After 12 Years?

March 27, 2020

News Daily News

Who Should Head to the Cath Lab in the COVID-19 Pandemic?

Michael O'Riordan

March 26, 2020

News Daily News

Center Site, Volume Affect Uptake of Same-Day Discharge for Elective PCI

L.A. McKeown

March 18, 2020

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

News Daily News

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

L.A. McKeown

March 09, 2020

News Conference News CRT 2020

Operator Volume Matters in Left Main PCI: BCIS Analysis

Michael O'Riordan

March 05, 2020

News Daily News CRT 2020

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

Michael O'Riordan

March 04, 2020

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

L.A. McKeown

February 25, 2020

News Conference News CRT 2020

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

Michael O'Riordan

February 24, 2020

News Conference News CRT 2020

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

Michael O'Riordan

February 24, 2020

News Daily News

BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns

Michael O'Riordan

February 21, 2020

Presentation JIM 2020

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presenter: Marco Valgimigli

February 13, 2020

Presentation JIM 2020

The Abluminus DES+: from the technical features to the clinical program

Presenter: Luca Testa

February 13, 2020

Advertisement

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

Conversations in Cardiology: Uncovered Struts on OCT After 12 Years?

Who Should Head to the Cath Lab in the COVID-19 Pandemic?

Center Site, Volume Affect Uptake of Same-Day Discharge for Elective PCI

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

Operator Volume Matters in Left Main PCI: BCIS Analysis

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

The Abluminus DES+: from the technical features to the clinical program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content